← Dashboard
Nov 17, 2026 05:58 AM ET
Signal
Corporate
Vivos Therapeutics GAAP EPS of -$0.07 beats by $0.25, revenue of $6.41M beats by $0.94M
Vivos beat EPS and revenue estimates by $0.25 and $0.94M respectively.
What changed
Vivos beat EPS and revenue estimates by $0.25 and $0.94M respectively.
Why it matters
Vivos beat EPS and revenue estimates by $0.25 and $0.94M respectively. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →
FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →
$FMX →